Correlation Between NovaBay Pharmaceuticals and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NovaBay Pharmaceuticals and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NovaBay Pharmaceuticals and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NovaBay Pharmaceuticals and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on NovaBay Pharmaceuticals and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NovaBay Pharmaceuticals with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NovaBay Pharmaceuticals and Crinetics Pharmaceuticals.
Diversification Opportunities for NovaBay Pharmaceuticals and Crinetics Pharmaceuticals
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between NovaBay and Crinetics is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding NovaBay Pharmaceuticals and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and NovaBay Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NovaBay Pharmaceuticals are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of NovaBay Pharmaceuticals i.e., NovaBay Pharmaceuticals and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between NovaBay Pharmaceuticals and Crinetics Pharmaceuticals
Considering the 90-day investment horizon NovaBay Pharmaceuticals is expected to under-perform the Crinetics Pharmaceuticals. In addition to that, NovaBay Pharmaceuticals is 1.87 times more volatile than Crinetics Pharmaceuticals. It trades about -0.27 of its total potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about -0.08 per unit of volatility. If you would invest 6,001 in Crinetics Pharmaceuticals on September 12, 2024 and sell it today you would lose (284.00) from holding Crinetics Pharmaceuticals or give up 4.73% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NovaBay Pharmaceuticals vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| NovaBay Pharmaceuticals |
| Crinetics Pharmaceuticals |
NovaBay Pharmaceuticals and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NovaBay Pharmaceuticals and Crinetics Pharmaceuticals
The main advantage of trading using opposite NovaBay Pharmaceuticals and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NovaBay Pharmaceuticals position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |